News | Advanced Visualization | July 28, 2025

The company was recognized for delivering diagnostic innovation, workflow efficiency and enterprise imaging leadership through advanced visualization solutions.

Siemens Healthineers Named Company of the Year by Frost & Sullivan

July 28, 2025 — Frost & Sullivan has named Siemens Healthineers the 2025 North America Company of the Year in the advanced visualization applications industry for its outstanding achievements in diagnostic innovation, seamless platform integration, and customer impact. This recognition underscores Siemens Healthineers' market leadership in transforming medical imaging with intelligent automation, scalable technology, and end-to-end workflow solutions.

Frost & Sullivan evaluates companies through a rigorous benchmarking process across two core dimensions: visionary innovation and customer impact. Siemens Healthineers excelled in both, demonstrating a compelling ability to align long-term product development with the evolving demands of healthcare systems while executing consistently across complex, high-stakes clinical environments. "By continuously translating real-world insights into high-performing solutions, Siemens Healthineers maintains its reputation as a preferred partner across global health systems," said Anantharaman Viswanathan, Research Director at Frost & Sullivan.

Guided by a focused growth strategy centered on organic development, digital innovation, and deep customer partnerships, Siemens Healthineers shapes the future of advanced visualization (AV) by delivering scalable, integrated platforms that enhance diagnostic confidence and operational agility. The company's sustained investment in intelligent imaging software and adaptive workflow integration has enabled it to lead in a sector increasingly defined by complexity, interoperability, and performance at scale.

At the core of Siemens Healthineers' AV leadership is its syngo.via platform, which powers disease-specific, multi-modality applications for specialties such as radiology, oncology, neurology, and cardiology. Seamlessly integrated with the company's enterprise imaging backbone, Syngo Carbon, syngo.via offers 3D and 4D visualization, AI-enabled segmentation, and robust quantitative analysis—all designed to empower clinicians to make fast and accurate decisions across the care continuum. The interoperability and modularity of this ecosystem distinguish it from fragmented solutions, allowing healthcare providers to standardize diagnostics, streamline data continuity, and reduce variability in interpretation.

Innovation extends beyond clinical tools to include Siemens Healthineers' delivery model. Unlike competitors that rely on external acquisitions, the company offers a fully homegrown ecosystem, engineered for consistency, security, and adaptability. Shared digital workspaces enable multi-site collaboration, ensuring that radiologists, referring physicians, and entire care teams can access and interpret imaging results regardless of location. These collaborative capabilities are further supported by structured reporting tools and embedded clinical decision support, which help unify diagnostic standards and promote evidence-based practice.

"We are honored to receive Frost & Sullivan's Company of the Year Award, which reflects our team's commitment to delivering meaningful innovation that drives clinical impact. Our advanced visualization portfolio empowers care teams with the tools they need to make efficient, more confident decisions across the entire patient journey," said Marcus da Silva, Head of Clinical and Efficiency Portfolio at Siemens Healthineers. "This recognition reinforces our mission to support health systems with scalable, intelligent solutions that enable better outcomes without compromise.

The company's commitment to implementation excellence is equally compelling. Siemens Healthineers provides structured onboarding that aligns with each organization's infrastructure and workflow. Built-in education modules, role-specific training, and ongoing professional development ensure rapid user adoption and reduce technical overhead. By aligning its technology with how clinicians work, the company drives high utilization efficiency and long-term system value.

Frost & Sullivan commends Siemens Healthineers for raising the bar in advanced visualization. By unifying clinical, operational, and financial priorities through a user-centric design philosophy, the company enables healthcare organizations to deliver improved patient outcomes—without compromise.

Each year, Frost & Sullivan presents the Company of the Year Award to a company that demonstrates outstanding strategy development and implementation, resulting in measurable improvements in market share, customer satisfaction, and competitive positioning. The award recognizes forward-thinking organizations that are reshaping their industries through innovation and growth excellence.

For more information, please visit www.frost.com and www.siemens-healthineers.com.

.


Related Content

News | Magnetic Resonance Imaging (MRI)

Feb. 5, 2026 — Eyas Medical Imaging, Inc. has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its ...

Time February 06, 2026
arrow
News | Ultrasound Women's Health

Feb. 5, 2026 — BrightHeart, a global provider of AI-driven prenatal ultrasound, has announced the availability of its B ...

Time February 05, 2026
arrow
News | Computed Tomography (CT)

Feb. 4, 2026 — A new review published in the American Journal of Roentgenology (AJR) finds that advances in CT ...

Time February 04, 2026
arrow
News | Radiation Therapy

Feb. 4, 2026 — On World Cancer Day (02.04.26), the American Society for Radiation Oncology (ASTRO) and the European ...

Time February 04, 2026
arrow
News | Radiology Imaging

Feb. 4, 2026 — The Royal College of Radiologists (RCR) has issued its initial reaction to the British government's ...

Time February 04, 2026
arrow
News | FDA

Feb. 2, 2026 — Imagion Biosystems, Ltd. has submitted an Investigational New Drug (IND) application with the U.S. Food ...

Time February 02, 2026
arrow
News | Radiopharmaceuticals and Tracers

Jan. 29, 2026 — The American Society for Radiation Oncology (ASTRO) has launched a national program creating Authorized ...

Time January 30, 2026
arrow
News | Breast Imaging | Washington University

Jan. 22, 2026 — In breast cancer, a biopsy is the only diagnostic procedure that can determine if a suspicious lump or ...

Time January 29, 2026
arrow
News | Radiation Oncology

Jan. 27, 2026 — Researchers at the Icahn School of Medicine at Mount Sinai, in collaboration with other leading ...

Time January 29, 2026
arrow
News | Radiology Education

Jan. 22, 2026—The American Roentgen Ray Society (ARRS) will host a live virtual symposium, "Medical Imaging for ...

Time January 28, 2026
arrow
Subscribe Now